SOURCE: Progressive Care Inc

Progressive Care Inc

May 09, 2016 08:00 ET

Progressive Care Engages PCAOB Accounting Firm: EisnerAmper

MIAMI, FL--(Marketwired - May 09, 2016) -  Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces that it has signed an agreement with EisnerAmper to perform reviews of the Company's financial statements.

On May 6, 2016, Progressive Care executed an agreement with EisnerAmper, LLP to perform quarterly review engagements with respect to the financial statements beginning with the Quarterly Report to be filed for the period ending March 31, 2016. EisnerAmper is one of the largest PCAOB accounting firms in the nation with nearly 1,300 employees and offices across the country. EisnerAmper is recognized internationally as one of the premier firms providing advisory, audit, and tax services.

While EisnerAmper will not be conducting audits at this time, the objective of this engagement is to provide reasonable assurance that the Firm is not aware of any material modification that should be made to the financial statements in accordance with generally accepted accounting principles (GAAP) in the United States. Upon completion of their review, the Firm will issue to the Board of Directors a report to be filed with the financial statements of the Company.

"We are looking forward to having our financial statements undergo a review by EisnerAmper, a reputable independent PCAOB accounting firm. This engagement will provide our shareholders and the investing public with increased confidence in the quarterly and annual financial statements filed with OTC markets," stated S. Parikh Mars, CEO.

About Progressive Care

Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.